(Q64132783)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

The natural history of chronic hepatitis B virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

1 reference

1 reference

1 reference

Brian J McMahon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

5 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

S45-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

26 January 2020

cites work

1 reference

7 January 2021

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

7 January 2021

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

1 reference

7 January 2021

Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study.

1 reference

7 January 2021

Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea

1 reference

7 January 2021

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

1 reference

7 January 2021

The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa

1 reference

7 January 2021

The long-term course of chronic hepatitis B.

1 reference

7 January 2021

Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers

1 reference

7 January 2021

Natural history and prognostic factors for chronic hepatitis type B

1 reference

7 January 2021

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

7 January 2021

Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

7 January 2021

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

7 January 2021

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

1 reference

7 January 2021

Management of hepatitis B: summary of a clinical research workshop

1 reference

7 January 2021

Management of hepatitis B: 2000--summary of a workshop

1 reference

7 January 2021

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

7 January 2021

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

1 reference

7 January 2021

A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children

1 reference

7 January 2021

Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F

1 reference

7 January 2021

Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase

1 reference

7 January 2021

Epidemiology and natural history of hepatitis B.

1 reference

7 January 2021

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

7 January 2021

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

7 January 2021

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

1 reference

7 January 2021

Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

1 reference

7 January 2021

Hepatitis B e antigen-negative chronic hepatitis B.

1 reference

7 January 2021

Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology

1 reference

7 January 2021

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

1 reference

7 January 2021

Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong

1 reference

7 January 2021

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

1 reference

7 January 2021

Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal

1 reference

7 January 2021

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

1 reference

7 January 2021

Precore mutant hepatitis B virus infection and liver disease

1 reference

7 January 2021

The natural history of asymptomatic hepatitis B surface antigen carriers

1 reference

7 January 2021

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers

1 reference

7 January 2021

Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).

1 reference

7 January 2021

Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.

1 reference

7 January 2021

Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study

1 reference

7 January 2021

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

1 reference

7 January 2021

HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up

1 reference

7 January 2021

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

1 reference

7 January 2021

Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

1 reference

7 January 2021

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

1 reference

7 January 2021

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection

1 reference

7 January 2021

Management of hepatocellular carcinoma

1 reference

7 January 2021

Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?

1 reference

7 January 2021

Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.

1 reference

7 January 2021

Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients

1 reference

7 January 2021

Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C.

1 reference

7 January 2021

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

1 reference

7 January 2021

Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease

1 reference

7 January 2021

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

1 reference

7 January 2021

Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F.

1 reference

7 January 2021

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

7 January 2021

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

7 January 2021

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

1 reference

7 January 2021

Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population

1 reference

7 January 2021

Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study

1 reference

7 January 2021

Hepatitis B virus genotypes in the United States: results of a nationwide study

1 reference

7 January 2021

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

1 reference

7 January 2021

Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.

1 reference

7 January 2021

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

1 reference

7 January 2021

Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus

1 reference

7 January 2021

Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis.

1 reference

7 January 2021

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

1 reference

7 January 2021

Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection

1 reference

7 January 2021

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22898

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19399792%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference